Literature DB >> 15904708

Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity.

Dean A Myers1, Matthew Gibson, Jay Schulkin, Beverley Greenwood Van-Meerveld.   

Abstract

Corticosterone (CORT) micropellets were stereotaxically placed bilaterally at the dorsal margin of the central nucleus of the amygdala (CeA). Both behavioral and physiological responses were recorded (plus maze and colonic discomfort) at 7 days post-implantation. Corticosterone reduced the exploration of the plus maze and increased colonic distress. The ability of a CRH type 1 receptor antagonist, antalarmin, to block behavioral and colonic effects of central placement of CORT was also examined. The diminished exploration in the plus maze and colon distress observed in response to CORT placement at the CeA were averted by the administration of antalarmin. These results provide further evidence for the role of the CRH type 1 receptor to ameliorate both behavioral and physiological functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15904708     DOI: 10.1016/j.bbr.2005.03.001

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

1.  Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques.

Authors:  S M Herod; C R Pohl; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

2.  Treatment with CRH-1 antagonist antalarmin reduces behavioral and endocrine responses to social stressors in marmosets (Callithrix kuhlii).

Authors:  Jeffrey A French; Jeffrey E Fite; Heather Jensen; Katie Oparowski; Michael R Rukstalis; Holly Fix; Brenda Jones; Heather Maxwell; Molly Pacer; Michael L Power; Jay Schulkin
Journal:  Am J Primatol       Date:  2007-08       Impact factor: 2.371

Review 3.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 4.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

5.  Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Authors:  Lee Tran; Jay Schulkin; Beverley Greenwood-Van Meerveld
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

6.  Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function.

Authors:  Michael J Weiser; Chad D Foradori; Robert J Handa
Journal:  Brain Res       Date:  2010-04-08       Impact factor: 3.252

7.  Behavioral effects of chronically elevated corticosterone in subregions of the medial prefrontal cortex.

Authors:  Joshua D Croteau; Jay Schulkin; Jack D Shepard
Journal:  Behav Brain Res       Date:  2016-08-28       Impact factor: 3.332

8.  Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear.

Authors:  D T Hubbard; B R Nakashima; I Lee; L K Takahashi
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

9.  Early-life stress disrupts attachment learning: the role of amygdala corticosterone, locus ceruleus corticotropin releasing hormone, and olfactory bulb norepinephrine.

Authors:  Stephanie Moriceau; Kiseko Shionoya; Katherine Jakubs; Regina M Sullivan
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

10.  Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors.

Authors:  Bing Mo; Na Feng; Kenneth Renner; Gina Forster
Journal:  Brain Res Bull       Date:  2008-03-04       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.